or Try an Advanced Search...

    Technical Analysis for PCSA - Processa Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.90 -1.08% -0.01
    PCSA closed up 1.34 percent on Wednesday, November 20, 2024, on 14 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PCSA trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup -1.08%
    Inside Day Range Contraction -1.08%
    Wide Bands Range Expansion -1.08%
    Oversold Stochastic Weakness -1.08%
    New 52 Week Closing Low Bearish 0.24%
    Expansion Breakdown Bearish Swing Setup 0.24%
    New 52 Week Low Weakness 0.24%
    Wide Bands Range Expansion 0.24%
    Down 3 Days in a Row Weakness 0.24%
    Down 4 Days in a Row Weakness 0.24%
    Older End-of-Day Signals for PCSA ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 3 hours ago
    Down 10% 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Down 5% 2 days ago
    Down 3% 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PCSA Chart by TradingView
    Basic chart:

    Profile

    Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drug Products

    Is PCSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 3 Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
    Sep 3 Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
    Aug 19 Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
    Jul 30 FDA approves Processa Phase 2 study for NGC-Cap, stock rallies 46%
    Jul 30 Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
    Jul 17 Processa Pharmaceuticals appoints CFO
    Jul 17 Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
    Jun 11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
    See more PCSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.4
    52 Week Low 0.85
    Average Volume 73,055
    200-Day Moving Average 1.76
    50-Day Moving Average 1.25
    20-Day Moving Average 1.13
    10-Day Moving Average 1.03
    Average True Range 0.08
    RSI (14) 24.24
    ADX 29.73
    +DI 10.65
    -DI 30.52
    Chandelier Exit (Long, 3 ATRs) 1.17
    Chandelier Exit (Short, 3 ATRs) 1.10
    Upper Bollinger Bands 1.40
    Lower Bollinger Band 0.86
    Percent B (%b) 0.09
    BandWidth 47.11
    MACD Line -0.09
    MACD Signal Line -0.07
    MACD Histogram -0.0206
    Fundamentals Value
    Market Cap 1.55 Million
    Num Shares 1.71 Million
    EPS -22.80
    Price-to-Earnings (P/E) Ratio -0.04
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.98
    Resistance 3 (R3) 0.98 0.96 0.97
    Resistance 2 (R2) 0.96 0.95 0.96 0.96
    Resistance 1 (R1) 0.94 0.94 0.95 0.93 0.96
    Pivot Point 0.92 0.92 0.93 0.92 0.92
    Support 1 (S1) 0.89 0.90 0.91 0.89 0.86
    Support 2 (S2) 0.87 0.89 0.87 0.86
    Support 3 (S3) 0.85 0.87 0.85
    Support 4 (S4) 0.84